|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
US7244853B2
(en)
|
2001-05-09 |
2007-07-17 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
|
US7154002B1
(en)
|
2002-10-08 |
2006-12-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US7375228B2
(en)
|
2003-03-17 |
2008-05-20 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
DE602004027824D1
(de)
|
2003-09-25 |
2010-08-05 |
Astellas Pharma Inc |
Antitumorales mittel mit einem histon-deacetylase-hemmer und einem topoisomerase-ii-hemmer
|
|
EP1712552A1
(en)
*
|
2005-04-11 |
2006-10-18 |
INDENA S.p.A. |
Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
|
|
US7446126B2
(en)
*
|
2004-10-08 |
2008-11-04 |
Indena S.P.A. |
Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel
|
|
US7642275B2
(en)
|
2004-12-16 |
2010-01-05 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
JP2008533053A
(ja)
*
|
2005-03-11 |
2008-08-21 |
ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド |
ヒストン脱アセチル化酵素阻害剤は、がん細胞を上皮増殖因子受容体阻害剤に対して感受性にする
|
|
SG171690A1
(en)
|
2005-03-22 |
2011-06-29 |
Harvard College |
Treatment of protein degradation disorders
|
|
JP2008540574A
(ja)
|
2005-05-11 |
2008-11-20 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
|
CA2615105A1
(en)
|
2005-07-14 |
2007-01-25 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
WO2008091349A1
(en)
|
2006-02-14 |
2008-07-31 |
The President And Fellows Of Harvard College |
Bifunctional histone deacetylase inhibitors
|
|
DK2010168T3
(da)
|
2006-02-14 |
2014-07-21 |
Harvard College |
Histondeacetylase-inhibitore
|
|
WO2007130429A2
(en)
|
2006-05-03 |
2007-11-15 |
The President And Fellows Of Harvard College |
Histone deacetylase and tubulin deacetylase inhibitors
|
|
GB0625283D0
(en)
*
|
2006-12-19 |
2007-01-24 |
Cyclacel Ltd |
Combination
|
|
PT2099442E
(pt)
*
|
2006-12-26 |
2015-02-10 |
Pharmacyclics Inc |
Métodos de utilização de inibidores de histona desacetilase e monitorização de biomarcadores em terapia de combinação
|
|
WO2009067453A1
(en)
*
|
2007-11-19 |
2009-05-28 |
Syndax Pharmaceuticals, Inc. |
Combinations of hdac inhibitors and proteasome inhibitors
|
|
US8293513B2
(en)
*
|
2007-12-14 |
2012-10-23 |
Georgetown University |
Histone deacetylase inhibitors
|
|
EP2321264B1
(en)
|
2008-07-23 |
2016-05-04 |
President and Fellows of Harvard College |
Deacetylase inhibitors and uses thereof
|
|
GB2462893B
(en)
*
|
2008-08-29 |
2010-10-13 |
Bayer Schering Pharma Ag |
N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B
|
|
RS52164B
(sr)
*
|
2008-08-29 |
2012-08-31 |
Bayer Pharma Aktiengesellschaft |
N-(2-aminofenil)-4-[n-(piridin-3-il)-metoksikarbonilaminometil]-benzamid (ms-275)polimorf b
|
|
PL3354650T3
(pl)
|
2008-12-19 |
2022-06-13 |
Vertex Pharmaceuticals Incorporated |
Związki przydatne jako inhibitory kinazy atr
|
|
US20120034302A1
(en)
*
|
2009-02-11 |
2012-02-09 |
Liangping Yu |
Particulate composition and the method of making the same
|
|
WO2010125462A2
(en)
*
|
2009-05-01 |
2010-11-04 |
Oncozyme Pharma Inc. |
Pentamidine combinations for treating cancer
|
|
CA2763786C
(en)
*
|
2009-06-08 |
2014-09-30 |
Gilead Sciences, Inc. |
Alkanoylamino benzamide aniline hdac inihibitor compounds
|
|
US8716344B2
(en)
|
2009-08-11 |
2014-05-06 |
President And Fellows Of Harvard College |
Class- and isoform-specific HDAC inhibitors and uses thereof
|
|
BR112012004149A2
(pt)
*
|
2009-08-25 |
2016-03-22 |
Abraxis Bioscience Llc |
terapia de combinação com composições de nanopartículas de taxano e inibidores de hedgehog
|
|
JP5836367B2
(ja)
|
2010-05-12 |
2015-12-24 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
Atrキナーゼ阻害剤として有用な化合物
|
|
UA110853C2
(uk)
|
2011-09-13 |
2016-02-25 |
Фармасайклікс, Інк. |
Лікарські форми інгібітора гістондеацетилази у комбінації з бендамустином та їхнє застосування
|
|
AU2012315384B2
(en)
|
2011-09-30 |
2017-08-10 |
Vertex Pharmaceuticals Incorporated |
Treating pancreatic cancer and non-small cell lung cancer with ATR inhibitors
|
|
RU2018147217A
(ru)
|
2011-09-30 |
2019-01-18 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способы получения соединений, которые можно использовать в качестве ингибиторов киназы atr
|
|
WO2013085902A1
(en)
*
|
2011-12-05 |
2013-06-13 |
The University Of Texas M.D. |
Combination therapy methods for treating an inflammatory breast cancer
|
|
CN104582795B
(zh)
|
2012-04-05 |
2018-04-20 |
沃泰克斯药物股份有限公司 |
可用作atr激酶抑制剂的化合物及其组合疗法
|
|
DK2904406T3
(en)
|
2012-10-04 |
2018-06-18 |
Vertex Pharma |
METHOD OF DETERMINING THE ATR INHIBITION, INCREASED DNA DAMAGE
|
|
JP6320506B2
(ja)
|
2013-03-12 |
2018-05-09 |
セルジーン クオンティセル リサーチ,インク. |
ヒストンデメチラーゼ阻害剤
|
|
US9963452B2
(en)
*
|
2013-03-14 |
2018-05-08 |
Augusta Pharmaceuticals Inc. |
Methods, compounds, and compositions for inhibition of ROS
|
|
EA201592012A8
(ru)
*
|
2014-02-21 |
2018-10-31 |
Общество С Ограниченной Ответственностью "Биолаб 612" |
Применение флагеллина для улучшенной химиотерапии
|
|
SG11201702119PA
(en)
|
2014-09-17 |
2017-04-27 |
Quanticel Pharmaceuticals Inc |
Histone demethylase inhibitors
|
|
US11464774B2
(en)
|
2015-09-30 |
2022-10-11 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
|
|
TWI794171B
(zh)
|
2016-05-11 |
2023-03-01 |
美商滬亞生物國際有限公司 |
Hdac抑制劑與pd-l1抑制劑之組合治療
|
|
TWI808055B
(zh)
|
2016-05-11 |
2023-07-11 |
美商滬亞生物國際有限公司 |
Hdac 抑制劑與 pd-1 抑制劑之組合治療
|
|
US11596612B1
(en)
|
2022-03-08 |
2023-03-07 |
PTC Innovations, LLC |
Topical anesthetics
|
|
WO2025041160A1
(en)
*
|
2023-08-19 |
2025-02-27 |
Birla Institute Of Technology And Science (Bits), Pilani |
Bifunctional conjugate molecules for cancer treatment and process of making the same
|